Related references
Note: Only part of the references are listed.Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments
Angelo Della Corte et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2023)
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
Josep M. Llovet et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2022)
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
Heejoon Jang et al.
HEPATOLOGY (2022)
Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis
Masatoshi Kudo et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
Jungnam Lee et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery
Matteo Canale et al.
HPB (2022)
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed Omar Kaseb et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Thomas U. Marron et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Survival update of neoadjuvant ipilimumab + nivolumab in macroscopic stage III melanoma: The OpACIN and OpACIN-neo trials.
Judith M. Versluis et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M. Rimini et al.
ESMO OPEN (2022)
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Immunobiology and pathogenesis of hepatitis B virus infection
Matteo Iannacone et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
Jonggi Choi et al.
HEPATOLOGY (2021)
Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
Xiaofei Li et al.
FRONTIERS IN MEDICINE (2021)
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Won Sohn et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
Takuji Torimura et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Roberta Zappasodi et al.
NATURE (2021)
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers
Maya S. Krishnan et al.
HEPATOLOGY (2021)
Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias
Yi-Hao Yen et al.
PLOS ONE (2021)
Epidemiology and risk-stratification of NAFLD-associated HCC
George N. Ioannou
JOURNAL OF HEPATOLOGY (2021)
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Won Jin Ho et al.
NATURE CANCER (2021)
Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma
Salvatore Lorenzo Renne et al.
HEPATOLOGY (2020)
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
Yen-Hsiang Liao et al.
BMC GASTROENTEROLOGY (2020)
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Min Woo Lee et al.
EUROPEAN RADIOLOGY (2020)
Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy
Alessandro Vitale et al.
HEPATOLOGY (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients
Margaux Hermida et al.
CANCERS (2020)
Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria
Diamantis I. Tsilimigras et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
Md. Mohaimenul Islam et al.
CANCERS (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of a fully automated Idylla test system for microsatellite instability in a cohort of Spanish patients with colorectal carcinoma in a single institution
L. Carnerero Cordoba et al.
ANNALS OF ONCOLOGY (2020)
Immune surveillance of the liver by T cells
Xenia Ficht et al.
SCIENCE IMMUNOLOGY (2020)
Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment
Sun Ah Kim et al.
SCIENTIFIC REPORTS (2020)
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?
Charlotte E. Costentin et al.
HEPATOLOGY (2019)
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Derek J. Erstad et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Teng-Yu Lee et al.
JAMA INTERNAL MEDICINE (2019)
Macrotrabecular Hepatocellular Carcinoma An Aggressive Subtype of Hepatocellular Carcinoma
Yejoo Jeon et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2019)
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma
Julien Calderaro et al.
CLINICAL CANCER RESEARCH (2019)
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Tracey G. Simon et al.
ANNALS OF INTERNAL MEDICINE (2019)
Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers
Reto Bale et al.
HEPATOLOGY (2019)
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
Adam Doyle et al.
JOURNAL OF HEPATOLOGY (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis
Kavita Radhakrishnan et al.
HEPATOLOGY COMMUNICATIONS (2019)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma
Matteo Canale et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
Aileen Baecker et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
Marianne Ziol et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
Jeanne-Marie Giard et al.
TRANSPLANTATION (2018)
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study
Jian Liu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
In Cheol Hwang et al.
SCIENTIFIC REPORTS (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Anthony W. H. Chan et al.
JOURNAL OF HEPATOLOGY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
Andrea Casadei Gardini et al.
ONCOTARGETS AND THERAPY (2018)
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
Tracey G. Simon et al.
JAMA ONCOLOGY (2018)
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma
Long-Hai Feng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection
Hui Zhao et al.
ONCOTARGET (2017)
Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
Minjong Lee et al.
HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
Stacey B. Prenner et al.
JOURNAL OF HEPATOLOGY (2017)
Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma
Yong Keun Park et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
Hyo Jung Cho et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion
Hui Zhao et al.
ONCOTARGET (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection
Pei-Chang Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
Chloe Sauzay et al.
CLINICA CHIMICA ACTA (2016)
Sex and Ethnic Differences in the Association of Obesity With Risk of Hepatocellular Carcinoma
Veronica Wendy Setiawan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Jing Liu et al.
CANCER DISCOVERY (2016)
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Elisabetta Degasperi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular Carcinoma
Ju Hyun Shim et al.
ANNALS OF SURGERY (2015)
The role of hepatic resection in the treatment of hepatocellular cancer
Sasan Roayaie et al.
HEPATOLOGY (2015)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner
Jian-Hong Fang et al.
HEPATOLOGY (2015)
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
Luca Vigano et al.
JOURNAL OF HEPATOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Combinations of Biomarkers and Milan Criteria for Predicting Hepatocellular Carcinoma Recurrence After Liver Transplantation
Roongruedee Chaiteerakij et al.
LIVER TRANSPLANTATION (2015)
The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma
Soo Fan Ang et al.
PLOS ONE (2015)
New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation
Tomohiro Iguchi et al.
TRANSPLANTATION (2015)
Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis
Bo Wei Xia et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection
Sha Huang et al.
PLOS ONE (2015)
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma
Shuji Sumie et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma
Min Du et al.
BMC CANCER (2014)
Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation
Surachate Siripongsakun et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
Kaoru Tsuchiya et al.
LIVER TRANSPLANTATION (2014)
Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for Liver Transplantation in Patients With Hepatocellular Carcinoma Meeting the Milan Criteria
Bilal Hameed et al.
LIVER TRANSPLANTATION (2014)
Nucleot(s)ide Analogues for Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Treatment: A Systematic Review and Meta-Analysis
Ping Sun et al.
PLOS ONE (2014)
Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
Dong Ho Lee et al.
RADIOLOGY (2014)
Above 5 cm, Size Does Not Matter Anymore in Patients with Hepatocellular Carcinoma
Chetana Lim et al.
WORLD JOURNAL OF SURGERY (2014)
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group
Guido Torzilli et al.
ANNALS OF SURGERY (2013)
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol et al.
JOURNAL OF HEPATOLOGY (2013)
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors
Young-sun Kim et al.
JOURNAL OF HEPATOLOGY (2013)
Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma
Toshimi Kaido et al.
SURGERY (2013)
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
Shuichiro Shiina et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China
Liguo Liu et al.
AMERICAN JOURNAL OF SURGERY (2012)
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy
W. -Y. Kao et al.
CLINICAL RADIOLOGY (2012)
High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: A prospective cohort study
T. Yang et al.
EJSO (2012)
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
Srinevas K. Reddy et al.
HEPATOLOGY (2012)
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma
Tsung-Han Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection
Hai-Tao Zhu et al.
PLOS ONE (2012)
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma
Toshiya Kamiyama et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria
S. T. Fan et al.
BRITISH JOURNAL OF SURGERY (2011)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation
Ken Shirabe et al.
CLINICAL TRANSPLANTATION (2011)
Tumor Marker Levels Before and After Curative Treatment of Hepatocellular Carcinoma as Predictors of Patient Survival
Atsushi Nanashima et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma
Sun Och Yoon et al.
HUMAN PATHOLOGY (2011)
Gene-expression signature of vascular invasion in hepatocellular carcinoma
Beatriz Minguez et al.
JOURNAL OF HEPATOLOGY (2011)
MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
Fumiaki Sato et al.
PLOS ONE (2011)
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
Jiwei Huang et al.
ANNALS OF SURGERY (2010)
Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
M. Fujiki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
Chih-Chi Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular Carcinoma
Masahiro Kobayashi et al.
CANCER (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie et al.
GASTROENTEROLOGY (2009)
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
Shuji Sumie et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Treatment of stage IVA hepatocellular carcinoma - Should we reappraise the role of surgery?
Mircea Chirica et al.
ARCHIVES OF SURGERY (2008)
Hepatectomy for Stage B and Stage C Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer Classification Results of a Prospective Analysis
Guido Torzilli et al.
ARCHIVES OF SURGERY (2008)
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
Takeaki Ishizawa et al.
GASTROENTEROLOGY (2008)
Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns
Yusuke Okuwaki et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2008)
Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma
Yo Sasaki et al.
ANNALS OF SURGERY (2006)
Prospective validation of the Barcelona Clinic Liver Cancer staging system
U Cillo et al.
JOURNAL OF HEPATOLOGY (2006)
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes
SA Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Early and late recurrence after liver resection for hepatocellular carcinoma - Prognostic and therapeutic implications
N Portolani et al.
ANNALS OF SURGERY (2006)
CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis
P Baumann et al.
CANCER RESEARCH (2005)
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma
TM Pawlik et al.
ARCHIVES OF SURGERY (2005)
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
C Cha et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus
M Minagawa et al.
ANNALS OF SURGERY (2001)
Share Paper
